1 Min Read
April 19 (Reuters) - Glenmark Pharmaceuticals Ltd:
* Receives tentative ANDA approval for Dabigatran Etexilate capsules, 75 mg, 110 mg and 150 mg Source text: bit.ly/2pfaBfp Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.